Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.094 | 0.002 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |